© 1993 Oxford University Press
RESEARCH-ARTICLE |
The interleukin-2 receptor 
chain maps to Xq13.1 and is mutated in X-linked severe combined immunodeficiency, SCIDX1
Departments of Pediatrics and Genetics, University of Pennsylvania School of Medicine and Children's Hospital of Philadelphia Philadelphia, PA 19104 1Center for Human Genetics and Department of Genetics, Case Western Reserve University Ceveland, OH 44106 2Department of Clinical Studies-Philadelphia, University of Pennsylvania School of Veterinary Medicine Philadelphia, PA, USA
* To whom correspondence should be addressed at: Division of Infectious Diseases and Immunology, Children's Hospital of Philadelphia, One Children's Center, Philadelphia, PA 19104, USA
Received June 1, 1993; Revised June 18, 1993; Accepted June 18, 1993
The gene encoding the 
chain of the lymphocyte interleukin-2 receptor has been cloned and shown to be required to associate with the ß chain in order for IL-2 internalization and cell activation to occur (1). We considered this gene, IL2RG, a candidate for the X-linked form of severe combined Immunodeficiency at the SCIDX1 locus, in which affected males have impaired lymphocyte development. Using fluorescence in situ hybridization and PCR amplification of somatic cell hybrid DNAs, we mapped IL2RG to human Xq13.1, a location within the SCIDX1 critical region established by linkage analysis. The 4.2 kb IL2RG gene was sequenced, and its genomlc organization was elucidated. Seven of 19 transformed B-lymphocyte cell lines with independent SCIDX1 mutations had absent or minimal IL2RG mRNA. Unique point mutations were documented to be specifically associated with the disease and the carrier state in four unrelated affected males and their family members: one in a boy with no detectable IL2RG mRNA, In which the mutation ablated a splice donor site; one causing premature chain termination; and two causing distinct amino acid changes. The demonstration of impaired IL2RG mRNA expression in males with X-linked SCID and of unique point mutations In SCIDX1 pedigrees constitutes powerful evidence that the SCIDX1 gene Is IL2RG. Noguchi et al. (2) have Independently published IL2RG mapping to Xq13 and discovery of mutations in three affected males. The specific pathogenesis of IL2RG mutations and approaches to gene therapy can now be addressed in the X-linked form of SCID.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  K. Liuba, C. J. H. Pronk, S. R. W. Stott, and S.-E. W. Jacobsen Polyclonal T-cell reconstitution of X-SCID recipients after in utero transplantation of lymphoid-primed multipotent progenitors Blood, May 7, 2009; 113(19): 4790 - 4798. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Roberts, J. P. H. Lauritsen, M. Cooney, R. E. Parrott, E. O. Sajaroff, C. M. Win, M. D. Keller, J. H. Carpenter, J. Carabana, M. S. Krangel, et al. T-B+NK+ severe combined immunodeficiency caused by complete deficiency of the CD3{zeta} subunit of the T-cell antigen receptor complex Blood, April 15, 2007; 109(8): 3198 - 3206. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. N. Silva-Teixeira, C. Contigli, J. R. Lambertucci, J. C. Serufo, and V. Rodrigues Jr. Gender-Related Cytokine Patterns in Sera of Schistosomiasis Patients with Symmers' Fibrosis Clin. Vaccine Immunol., May 1, 2004; 11(3): 627 - 630. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Roberts, A. Lengi, S. M. Brown, M. Chen, Y.-J. Zhou, J. J. O'Shea, and R. H. Buckley Janus kinase 3 (JAK3) deficiency: clinical, immunologic, and molecular analyses of 10 patients and outcomes of stem cell transplantation Blood, March 15, 2004; 103(6): 2009 - 2018. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Hiramatsu, R. Nishikomori, T. Heike, M. Ito, K. Kobayashi, K. Katamura, and T. Nakahata Complete reconstitution of human lymphocytes from cord blood CD34+ cells using the NOD/SCID/{gamma}cnull mice model Blood, August 1, 2003; 102(3): 873 - 880. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Sarzotti, D. D. Patel, X. Li, D. A. Ozaki, S. Cao, S. Langdon, R. E. Parrott, K. Coyne, and R. H. Buckley T Cell Repertoire Development in Humans with SCID After Nonablative Allogeneic Marrow Transplantation J. Immunol., March 1, 2003; 170(5): 2711 - 2718. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Cooper, L. L. Lanier, M. E. Conley, and J. M. Puck Immunodeficiency Disorders Hematology, January 1, 2003; 2003(1): 314 - 330. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. J. Tsai, H. L. Malech, M. R. Kirby, A. P. Hsu, N. E. Seidel, C. D. Porada, E. D. Zanjani, D. M. Bodine, and J. M. Puck Retroviral transduction of IL2RG into CD34+ cells from X-linked severe combined immunodeficiency patients permits human T- and B-cell development in sheep chimeras Blood, June 17, 2002; 100(1): 72 - 79. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. S. Rosen Successful Gene Therapy for Severe Combined Immunodeficiency N. Engl. J. Med., April 18, 2002; 346(16): 1241 - 1243. [Full Text] [PDF]
|
|
|
|
 |
|
 F. Olosz and T. R. Malek Structural Basis for Binding Multiple Ligands by the Common Cytokine Receptor gamma -Chain J. Biol. Chem., March 29, 2002; 277(14): 12047 - 12052. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Myers, D. D. Patel, J. M. Puck, and R. H. Buckley Hematopoietic stem cell transplantation for severe combined immunodeficiency in the neonatal period leads to superior thymic output and improved survival Blood, February 1, 2002; 99(3): 872 - 878. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Otsu, K. Sugamura, and F. Candotti Lack of dominant-negative effects of a truncated {gamma}c on retroviral-mediated gene correction of immunodeficient mice Blood, March 15, 2001; 97(6): 1618 - 1624. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. L. Monson, T. J. Fenske, S. Wei, A. J. Okragly, J. L.O. de Jong, M. Haak-Frendscho, J. O’Shea, J. Djeu, and P. M. Sondel A p74 common gamma receptor chain isoform facilitates IL-2 and IL-15 responses by the myelomonocytic cell line Tf-1{beta}2 J. Leukoc. Biol., March 1, 2001; 69(3): 419 - 425. [Abstract] [Full Text]
|
|
|
|
|
|
R. H. Buckley Primary Immunodeficiency Diseases Due to Defects in Lymphocytes N. Engl. J. Med., November 2, 2000; 343(18): 1313 - 1324. [Full Text] [PDF]
|
|
|
|
|
|
G. D. Sempowski, L. P. Hale, J. S. Sundy, J. M. Massey, R. A. Koup, D. C. Douek, D. D. Patel, and B. F. Haynes Leukemia Inhibitory Factor, Oncostatin M, IL-6, and Stem Cell Factor mRNA Expression in Human Thymus Increases with Age and Is Associated with Thymic Atrophy J. Immunol., February 15, 2000; 164(4): 2180 - 2187. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. Ward, I. Touw, and A. Yoshimura The Jak-Stat pathway in normal and perturbed hematopoiesis Blood, January 1, 2000; 95(1): 19 - 29. [Full Text] [PDF]
|
|
|
|
|
|
E. Haddad, F. L. Deist, P. Aucouturier, M. Cavazzana-Calvo, S. Blanche, G. D. S. Basile, and A. Fischer Long-Term Chimerism and B-Cell Function After Bone Marrow Transplantation in Patients With Severe Combined Immunodeficiency With B Cells: A Single-Center Study of 22 Patients Blood, October 15, 1999; 94(8): 2923 - 2930. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Villard, S. Briault, A.-M. Lossi, C. Paringaux, J. Belougne, L. Colleaux, D R Pincus, E Woollatt, J. Lespinasse, A. Munnich, et al. Two unrelated patients with inversions of the X chromosome and non-specific mental retardation: physical and transcriptional mapping of their common breakpoint region in Xq13.1 J. Med. Genet., October 1, 1999; 36(10): 754 - 758. [Abstract] [Full Text]
|
|
|
|
 |
|
 S.J. Millward-Sadler, M.O. Wright, H.-S. Lee, K. Nishida, H. Caldwell, G. Nuki, and D.M. Salter Integrin-regulated Secretion of Interleukin 4: A Novel Pathway of Mechanotransduction in Human Articular Chondrocytes J. Cell Biol., April 5, 1999; 145(1): 183 - 189. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. H. Buckley, S. E. Schiff, R. I. Schiff, M. L. Markert, L. W. Williams, J. L. Roberts, L. A. Myers, and F. E. Ward Hematopoietic Stem-Cell Transplantation for the Treatment of Severe Combined Immunodeficiency N. Engl. J. Med., February 18, 1999; 340(7): 508 - 516. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Raskin, A. Jakubowski, I. Sizing, D. L. Olson, S. L. Kalled, C. A. Hession, C. D. Benjamin, D. P. Baker, and L. C. Burkly Molecular Mapping with Functional Antibodies Localizes Critical Sites on the Human IL Receptor Common {gamma} ({gamma}c) Chain J. Immunol., October 1, 1998; 161(7): 3474 - 3483. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Whitwam, M. E. Haskins, P. S. Henthorn, J. N. Kraszewski, S. E. Kleiman, N. E. Seidel, D. M. Bodine, and J. M. Puck Retroviral Marking of Canine Bone Marrow: Long-Term, High-Level Expression of Human Interleukin-2 Receptor Common Gamma Chain in Canine Lymphocytes Blood, September 1, 1998; 92(5): 1565 - 1575. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. S. Rosen and A. K. Bhan Case 18-1998- A 54-Day-Old Premature Girl with Respiratory Distress and Persistent Pulmonary Infiltrates N. Engl. J. Med., June 11, 1998; 338(24): 1752 - 1758. [Full Text] [PDF]
|
|
|
|
|
|
H. Ueno, K. Sasaki, H. Honda, T. Nakamoto, T. Yamagata, K. Miyagawa, K. Mitani, Y. Yazaki, and H. Hirai c-Cbl Is Tyrosine-Phosphorylated by Interleukin-4 and Enhances Mitogenic and Survival Signals of Interleukin-4 Receptor by Linking With the Phosphatidylinositol 3'-Kinase Pathway Blood, January 1, 1998; 91(1): 46 - 53. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Puck Primary Immunodeficiency Diseases JAMA, December 10, 1997; 278(22): 1835 - 1841. [Abstract] [PDF]
|
|
|
|
|
|
P. J. Felsburg, R. L. Somberg, B. J. Hartnett, S. F. Suter, P. S. Henthorn, P. F. Moore, K. I. Weinberg, and H. D. Ochs Full Immunologic Reconstitution Following Nonconditioned Bone Marrow Transplantation for Canine X-Linked Severe Combined Immunodeficiency Blood, October 15, 1997; 90(8): 3214 - 3221. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Puck, A. E. Pepper, P. S. Henthorn, F. Candotti, J. Isakov, T. Whitwam, M. E. Conley, R. E. Fischer, H. M. Rosenblatt, T. N. Small, et al. Mutation Analysis of IL2RG in Human X-Linked Severe Combined Immunodeficiency Blood, March 15, 1997; 89(6): 1968 - 1977. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Taylor, F. Candotti, S. Smith, S. A. Oakes, T. Jahn, J. Isakov, J. M. Puck, J. J. O'Shea, K. Weinberg, and J. A. Johnston Interleukin-4 Signaling in B Lymphocytes from Patients with X-linked Severe Combined Immunodeficiency J. Biol. Chem., March 14, 1997; 272(11): 7314 - 7319. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. H. Nelson, B. C. McIntosh, L. L. Rosencrans, and P. D. Greenberg Requirement for an initial signal from the membrane-proximal region of the interleukin 2 receptor gamma c chain for Janus kinase activation leading to T cell proliferation PNAS, March 4, 1997; 94(5): 1878 - 1883. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. W. Flake, M.-G. Roncarolo, J. M. Puck, G. Almeida-Porada, M. I. Evans, M. P. Johnson, E. M. Abella, D. D. Harrison, and E. D. Zanjani Treatment of X-Linked Severe Combined Immunodeficiency by in Utero Transplantation of Paternal Bone Marrow N. Engl. J. Med., December 12, 1996; 335(24): 1806 - 1810. [Full Text] [PDF]
|
|
|
|
|
|
V. Stephan, V. Wahn, F. Le Deist, U. Dirksen, B. Broker, I. Muller-Fleckenstein, G. Horneff, H. Schroten, A. Fischer, and G. de Saint Basile Atypical X-Linked Severe Combined Immunodeficiency Due to Possible Spontaneous Reversion of the Genetic Defect in T Cells N. Engl. J. Med., November 21, 1996; 335(21): 1563 - 1567. [Full Text] [PDF]
|
|
|
|
|
|
K. Izuhara, T. Heike, T. Otsuka, K. Yamaoka, M. Mayumi, T. Imamura, Y. Niho, and N. Harada Signal Transduction Pathway of Interleukin-4 and Interleukin-13 in Human B Cells Derived from X-linked Severe Combined Immunodeficiency Patients J. Biol. Chem., January 12, 1996; 271(2): 619 - 622. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Boussiotis, D. Barber, T Nakarai, G. Freeman, J. Gribben, G. Bernstein, A. D'Andrea, J Ritz, and L. Nadler Prevention of T cell anergy by signaling through the gamma c chain of the IL-2 receptor Science, November 11, 1994; 266(5187): 1039 - 1042. [Abstract] [PDF]
|
|